124 related articles for article (PubMed ID: 15781067)
1. Prevention of brain infarction by postischemic administration of histidine in rats.
Adachi N; Liu K; Arai T
Brain Res; 2005 Mar; 1039(1-2):220-3. PubMed ID: 15781067
[TBL] [Abstract][Full Text] [Related]
2. Alleviation of ischemic neuronal damage by postischemic loading with histidine in the rat striatum.
Adachi N; Liu K; Arai T
Brain Res; 2004 Feb; 998(1):136-8. PubMed ID: 14725977
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia.
Zhang HL; Huang ZH; Zhu Y; Liang ZQ; Han R; Wang XX; Chase TN; Qin ZH
Brain Res; 2005 Mar; 1039(1-2):203-6. PubMed ID: 15781063
[TBL] [Abstract][Full Text] [Related]
4. Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains.
Hiraga N; Adachi N; Liu K; Nagaro T; Arai T
Eur J Pharmacol; 2007 Feb; 557(2-3):236-44. PubMed ID: 17169356
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the infarct size by simultaneous administration of L-histidine and diphenhydramine in ischaemic rat brains.
Adachi N; Liu K; Ninomiya K; Matsuoka E; Motoki A; Irisawa Y; Nishibori M
Resuscitation; 2011 Feb; 82(2):219-21. PubMed ID: 21131122
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of ischemia-induced brain edema by activation of the central histaminergic system in rats.
Irisawa Y; Adachi N; Liu K; Arai T; Nagaro T
J Pharmacol Sci; 2008 Sep; 108(1):112-23. PubMed ID: 18787305
[TBL] [Abstract][Full Text] [Related]
7. Peripheral administration of carbenoxolone reduces ischemic reperfusion injury in transient model of cerebral ischemia.
Vakili A; Hosseinzadeh SA; Khorasani MZ
J Stroke Cerebrovasc Dis; 2009; 18(2):81-5. PubMed ID: 19251182
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats.
Adachi N; Liu K; Motoki A; Nishibori M; Arai T
Eur J Pharmacol; 2006 Aug; 544(1-3):181-7. PubMed ID: 16860312
[TBL] [Abstract][Full Text] [Related]
9. Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model.
Nakagawa T; Suga S; Kawase T; Toda M
Brain Res; 2006 May; 1089(1):179-85. PubMed ID: 16678804
[TBL] [Abstract][Full Text] [Related]
10. Histaminergic system of the lateral septum in the modulation of anxiety-like behaviour in rats.
Zarrindast MR; Valizadegan F; Rostami P; Rezayof A
Eur J Pharmacol; 2008 Mar; 583(1):108-14. PubMed ID: 18275952
[TBL] [Abstract][Full Text] [Related]
11. Rutin protects the neural damage induced by transient focal ischemia in rats.
Khan MM; Ahmad A; Ishrat T; Khuwaja G; Srivastawa P; Khan MB; Raza SS; Javed H; Vaibhav K; Khan A; Islam F
Brain Res; 2009 Oct; 1292():123-35. PubMed ID: 19631195
[TBL] [Abstract][Full Text] [Related]
12. Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
Briyal S; Gulati A; Gupta YK
Methods Find Exp Clin Pharmacol; 2007 May; 29(4):257-63. PubMed ID: 17609737
[TBL] [Abstract][Full Text] [Related]
13. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
14. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
[TBL] [Abstract][Full Text] [Related]
15. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
17. The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia.
Melani A; Gianfriddo M; Vannucchi MG; Cipriani S; Baraldi PG; Giovannini MG; Pedata F
Brain Res; 2006 Feb; 1073-1074():470-80. PubMed ID: 16443200
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
Ikeda Y; Hokamura K; Kawai T; Ishiyama J; Ishikawa K; Anraku T; Uno T; Umemura K
Brain Res; 2005 Oct; 1060(1-2):73-80. PubMed ID: 16202986
[TBL] [Abstract][Full Text] [Related]
19. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke.
Xu Z; Croslan DR; Harris AE; Ford GD; Ford BD
J Cereb Blood Flow Metab; 2006 Apr; 26(4):527-35. PubMed ID: 16136057
[TBL] [Abstract][Full Text] [Related]
20. Central H1 and H2 receptor participation in the control of water and salt intake in rats.
Magrani J; de Castro e Silva E; Ramos AC; Athanazio R; Barbetta M; Fregoneze JB
Physiol Behav; 2005 Feb; 84(2):233-43. PubMed ID: 15708775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]